These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10854698)

  • 21. Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimers: intermolecular synergy requires only the PPARgamma hormone-dependent activation function.
    Schulman IG; Shao G; Heyman RA
    Mol Cell Biol; 1998 Jun; 18(6):3483-94. PubMed ID: 9584188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid hormone receptor beta mutants: Dominant negative regulators of peroxisome proliferator-activated receptor gamma action.
    Araki O; Ying H; Furuya F; Zhu X; Cheng SY
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16251-6. PubMed ID: 16260719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptor (PPAR) gamma coactivator-1 recruitment regulates PPAR subtype specificity.
    Oberkofler H; Esterbauer H; Linnemayr V; Strosberg AD; Krempler F; Patsch W
    J Biol Chem; 2002 May; 277(19):16750-7. PubMed ID: 11875072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adipocyte low density lipoprotein receptor-related protein gene expression and function is regulated by peroxisome proliferator-activated receptor gamma.
    Gauthier A; Vassiliou G; Benoist F; McPherson R
    J Biol Chem; 2003 Apr; 278(14):11945-53. PubMed ID: 12551936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells.
    Gupta RA; Brockman JA; Sarraf P; Willson TM; DuBois RN
    J Biol Chem; 2001 Aug; 276(32):29681-7. PubMed ID: 11397807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoid X receptor and peroxisome proliferator-activated receptor activate an estrogen responsive gene independent of the estrogen receptor.
    Nuñez SB; Medin JA; Braissant O; Kemp L; Wahli W; Ozato K; Segars JH
    Mol Cell Endocrinol; 1997 Mar; 127(1):27-40. PubMed ID: 9099898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
    Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
    Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calreticulin modulates the in vitro DNA binding but not the in vivo transcriptional activation by peroxisome proliferator-activated receptor/retinoid X receptor heterodimers.
    Winrow CJ; Miyata KS; Marcus SL; Burns K; Michalak M; Capone JP; Rachubinski RA
    Mol Cell Endocrinol; 1995 Jun; 111(2):175-9. PubMed ID: 7556879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects.
    Berger J; Leibowitz MD; Doebber TW; Elbrecht A; Zhang B; Zhou G; Biswas C; Cullinan CA; Hayes NS; Li Y; Tanen M; Ventre J; Wu MS; Berger GD; Mosley R; Marquis R; Santini C; Sahoo SP; Tolman RL; Smith RG; Moller DE
    J Biol Chem; 1999 Mar; 274(10):6718-25. PubMed ID: 10037770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subtype- and response element-dependent differences in transactivation by peroxisome proliferator-activated receptors alpha and gamma.
    Kassam A; Hunter J; Rachubinski RA; Capone JP
    Mol Cell Endocrinol; 1998 Jun; 141(1-2):153-62. PubMed ID: 9723896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective intranuclear redistribution of PPAR isoforms by RXR alpha.
    Akiyama TE; Baumann CT; Sakai S; Hager GL; Gonzalez FJ
    Mol Endocrinol; 2002 Apr; 16(4):707-21. PubMed ID: 11923467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression.
    Marcus SL; Miyata KS; Zhang B; Subramani S; Rachubinski RA; Capone JP
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5723-7. PubMed ID: 8390676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity.
    Gervois P; Torra IP; Chinetti G; Grötzinger T; Dubois G; Fruchart JC; Fruchart-Najib J; Leitersdorf E; Staels B
    Mol Endocrinol; 1999 Sep; 13(9):1535-49. PubMed ID: 10478844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
    Crowe DL; Chandraratna RA
    Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of the fatty acid transport protein 1 and acyl-CoA synthase genes by dimer-selective rexinoids suggests that the peroxisome proliferator-activated receptor-retinoid X receptor heterodimer is their molecular target.
    Martin G; Poirier H; Hennuyer N; Crombie D; Fruchart JC; Heyman RA; Besnard P; Auwerx J
    J Biol Chem; 2000 Apr; 275(17):12612-8. PubMed ID: 10777552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloning and characterization of a functional peroxisome proliferator activator receptor-gamma-responsive element in the promoter of the CAP gene.
    Baumann CA; Chokshi N; Saltiel AR; Ribon V
    J Biol Chem; 2000 Mar; 275(13):9131-5. PubMed ID: 10734046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Addition of peroxisome proliferator-activated receptor alpha to guinea pig hepatocytes confers increased responsiveness to peroxisome proliferators.
    Macdonald N; Holden PR; Roberts RA
    Cancer Res; 1999 Oct; 59(19):4776-80. PubMed ID: 10519382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.
    Shipley JM; Waxman DJ
    Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.
    Leesnitzer LM; Parks DJ; Bledsoe RK; Cobb JE; Collins JL; Consler TG; Davis RG; Hull-Ryde EA; Lenhard JM; Patel L; Plunket KD; Shenk JL; Stimmel JB; Therapontos C; Willson TM; Blanchard SG
    Biochemistry; 2002 May; 41(21):6640-50. PubMed ID: 12022867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
    Kim MJ; Deplewski D; Ciletti N; Michel S; Reichert U; Rosenfield RL
    Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.